High expression of MLANA in the plasma of patients with head and neck squamous cell carcinoma as a predictor of tumor progression.

Dorival Mendes Rodrigues-JuniorSoon Sim TanSai Kiang LimLuciano de Souza VianaAndre Lopes CarvalhoAndre Luiz VettoreNarayanan Gopalakrishna Iyer

Published in: Head & neck (2019)

Plasma MLANA expression appears to be an effective noninvasive biomarker for outcomes in patients treated with CRT, and could potentially guide therapeutic decisions in this context.

Keyphrases

poor prognosis
long non coding rna
binding protein
heart failure
metabolic syndrome
atrial fibrillation
skeletal muscle
cardiac resynchronization therapy
weight loss